Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tzu-Ting Huang

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Breast Cancer Cells

Cell Proliferation

Top Venues

Cancer research

Experimental & molecular medicine

Science translational medicine

National Cancer Institute

National Yang-Ming University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute

United States

CRTA Postdoc Fellow

Education History

National Yang-Ming University School of Medicine

Taiwan

PHD :: Department and Institute of Pharmacology

Publications

Nitasha Gupta, Tzu-Ting Huang, Jayakumar R Nair, Daniel An, Grant Zurcher, Erika J Lampert, Ann McCoy, Ashley Cimino-Mathews, Elizabeth M Swisher, Marc R Radke, Christina M Lockwood, Jonathan B Reichel, Chih-Yuan Chiang, Kelli M Wilson, Ken Chih-Chien Cheng, Darryl Nousome, Jung-Min Lee
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA -mutant ovarian cancer. Science translational medicine 15 (701) (2023)
Tzu-Ting Huang, Ethan Brill, Jayakumar R Nair, Xiaohu Zhang, Kelli M Wilson, Lu Chen, Craig J Thomas, Jung-Min Lee
Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer. Cancer research 80 (23) (2020)
Chun-Yu Liu, Pei-Yi Chu, Chun-Teng Huang, Ji-Lin Chen, Hsiu-Ping Yang, Wan-Lun Wang, Ka-Yi Lau, Chia-Han Lee, Tien-Yun Lan, Tzu-Ting Huang, Po-Han Lin, Ming-Shen Dai, Ling-Ming Tseng
Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells. Cancers 11 (1) (2019)
Chun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, Chun-Teng Huang, Chia-Han Lee, Wan-Lun Wang, Ka-Yi Lau, Wen-Chun Tsai, Tzu-I Chao, Jung-Chen Su, Ming-Huang Chen, Chung-Wai Shiau, Ling-Ming Tseng, Kuen-Feng Chen
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. Experimental & molecular medicine 49 (8) (2017)